Joshua Stender
机构: Project Scientist, University of California San Diego
每年引用次数
引用次数
引用: 4,281
H-指数: 19
I10-指数 : 19
出版物: 34
OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
S Bhatt , J D Stender , S Joshi , G Wu
Oncogene 35 ( 44) 5722 -5734
31
2016
Conserved role for autophagy in Rho1-mediated cortical remodeling and blood cell recruitment
P. Kadandale , J. D. Stender , C. K. Glass , A. A. Kiger
Proceedings of the National Academy of Sciences of the United States of America 107 ( 23) 10502 -10507
49
2010
Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output.
L. C. Trotman , C. K. Glass , A. C. Newton , G. Reyes
Proceedings of the National Academy of Sciences of the United States of America 111 ( 38)
20
2014
Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.
Keith B Glaser , Michael J Staver , Jeffrey F Waring , Joshua Stender
Molecular cancer therapeutics 2 ( 2) 151 -63
705
2003
Selective estrogen receptor modulators, gene regulation and breast cancer prevention.
Benita S Katzenellenbogen , Jonna Frasor , Daniel H Barnett , Edmund Chang
Cancer Research 64 ( 7_Supplement) 1317 -1318
2004
53BP1 and USP28 Mediate p53 Activation and G1 Arrest Following Centrosome Loss or Extended Mitotic Duration
F Meitinger , JV Anzola , M Kaulich , AK Richardson
MOLECULAR BIOLOGY OF THE CELL 27
2016
Diverse motif ensembles specify non-redundant DNA binding activities of AP-1 family members in macrophages.
Gregory J. Fonseca , Jenhan Tao , Emma M. Westin , Sascha H. Duttke
Nature Communications 10 ( 1) 414
17
2019
A Cell-Permeable Stapled Peptide Inhibitor of the Estrogen Receptor/Coactivator Interaction
Thomas E. Speltz , Jeanne M. Danes , Joshua D. Stender , Jonna Frasor
ACS Chemical Biology 13 ( 3) 676 -684
12
2018
NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.
Jonna Frasor , Lamiaa El-Shennawy , Joshua D. Stender , Irida Kastrati
Molecular and Cellular Endocrinology 418 235 -239
30
2015
Abstract LB-148: Inflammatory cytokines alter the sensitivity of breast cancer cells to endocrine treatments
Joshua D. Stender , Irida Kastrati , Maayan Yakir , Jonna Frasor
Cancer Research 74
2014
The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast Cancers.
Irida Kastrati , Stacey E. P. Joosten , Svetlana E. Semina , Luis H. Alejo
Molecular Cancer Research 18 ( 7) 1018 -1027
4
2020
Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells.
Joshua D. Stender , Jerome C. Nwachukwu , Irida Kastrati , Yohan Kim
Molecular Cell 65 ( 6) 1122 -1135
64
2017
Genome-Wide Analysis of Estrogen Receptor α DNA Binding and Tethering Mechanisms Identifies Runx1 as a Novel Tethering Factor in Receptor-Mediated Transcriptional Activation
Joshua D. Stender , Kyuri Kim , Tze Howe Charn , Barry Komm
Molecular and Cellular Biology 30 ( 16) 3943 -3955
159
2010
Nuclear Receptor Coactivators
Joshua D. Stender , Christopher K. Glass
Handbook of Cell Signaling 1999 -2004
2010
PHLPP1 Counter-regulates STAT1-mediated Inflammatory Signaling
Ksenya Cohen-Katsenelson , Joshua D. Stender , Agnieszka T. Kawashima , Gema Lordén
bioRxiv 647883
22
2019
53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration
Franz Meitinger , John V. Anzola , Manuel Kaulich , Amelia Richardson
Journal of Cell Biology 214 ( 2) 155 -166
113
2016
Estrogen-Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell Proliferation
Joshua D. Stender , Jonna Frasor , Barry Komm , Ken C. N. Chang
Molecular Endocrinology 21 ( 9) 2112 -2123
106
2007
The Estrogen-Regulated Transcription Factor PITX1 Coordinates Gene-Specific Regulation by Estrogen Receptor-Alpha in Breast Cancer Cells
Joshua D. Stender , Fabio Stossi , Cory C. Funk , Tze Howe Charn
Molecular Endocrinology 25 ( 10) 1699 -1709
15
2011
Epigenomic control of the innate immune response.
Joshua D Stender , Christopher K Glass
Current Opinion in Pharmacology 13 ( 4) 582 -587
35
2013
Selective Recognition of Distinct Classes of Coactivators by a Ligand-Inducible Activation Domain
Mari Luz Acevedo , Kathleen C Lee , Joshua D Stender , Benita S Katzenellenbogen
Molecular Cell 13 ( 5) 725 -738
55
2004